人类利用抗体疗法治疗传染性疾病已有100多年的历史。1912年,取自流感幸存者的血浆被注射进患者体内,而这可能为当时应对流感带来了重大转机。自此以后,来自幸存者的免疫蛋白被接种到感染者体内,以试图同拉沙热、非典型肺炎甚至埃博拉等疾病抗争。不过,要找到合格的幸存者并非易事,因为其捐献的血清中必须含有可挽救生命的免疫蛋白。如今,由美国陆军传染病医学研究所(USAM- Human use of antibody therapy for infectious diseases has been more than 100 years of history. In 1912, plasma taken from flu survivors was injected into the patient’s body, a move that could have taken a major turnaround when it came to flu. Since then, immune proteins from survivors have been vaccinated in infected individuals in an attempt to fight diseases such as Lassa fever, SARS and even Ebola. However, finding qualified survivors is not easy because the donated serum must contain life-saving immune proteins. Today, the United States Army Institute of Infectious Diseases (USAM-